Cas:36889-13-1 l-nio dihydrochloride manufacturer & supplier

We serve Chemical Name:l-nio dihydrochloride CAS:36889-13-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

l-nio dihydrochloride

Chemical Name:l-nio dihydrochloride
CAS.NO:36889-13-1
Synonyms:L-NIO,2HCL;L-NIO DIHYDROCHLORIDE;(E)-N-(1-Aminoethylidene)-L-ornithine dihydrochloride;L-NIO;L-N5-(1-Iminoethyl)-ornithine dihydrochloride;L-Ornithine, N-(1-aminoethylidene)-, (E)-, hydrochloride (1:2)
Molecular Formula:C7H17Cl2N3O2
Molecular Weight:246.135
HS Code:2924199090

Physical and Chemical Properties:
Melting point:225-226ºC
Boiling point:358.9ºC at 760 mmHg
Density:1.26 g/cm3
Index of Refraction:
PSA:99.20000
Exact Mass:245.069778
LogP:2.56020

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like L-NIO,2HCL chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,L-Ornithine, N-(1-aminoethylidene)-, (E)-, hydrochloride (1:2) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,L-NIO Use and application,L-N5-(1-Iminoethyl)-ornithine dihydrochloride technical grade,usp/ep/jp grade.


Related News: Like other countries in Southeast Asia, Indonesia depends heavily on Chinese tourism. On Thursday alone, 10,000 Chinese tourists canceled their trips to Bali, according to one industry association. l-nio dihydrochloride manufacturer During analysis of the clinical trial data, the researchers realized that about a third of the participants had low levels of abnormal tau protein, which makes them not very suitable for evaluating the effects of a treatment halting the progression of tau pathology. l-nio dihydrochloride supplier Targets within the tumor microenvironment may include both plasma membrane proteins as well as proteins typically secreted into the extracellular space. l-nio dihydrochloride vendor During analysis of the clinical trial data, the researchers realized that about a third of the participants had low levels of abnormal tau protein, which makes them not very suitable for evaluating the effects of a treatment halting the progression of tau pathology. l-nio dihydrochloride factory Targets within the tumor microenvironment may include both plasma membrane proteins as well as proteins typically secreted into the extracellular space.